|
[1]
|
Abuzaanona, A. and Lanfear, D. (2017) Pharmacogenomics of the Natriuretic Peptide System in Heart Failure. Current Heart Failure Reports, 14, 536-542. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
吴华芹, 张并璇, 李雨濛, 等. 慢性心力衰竭病人血清CA125水平与心功能的相关性研究[J]. 中西医结合心脑血管病杂志, 2020, 18(18): 2955-2958.
|
|
[3]
|
Chen, Y.X., Wang, X.Q., Fang, C.F., et al. (2008) Value of BNP and Tumour Marker CA125 in Patients with Heart Failure. Acta Cardiologica, 63, 501-506. [Google Scholar] [CrossRef]
|
|
[4]
|
中华医学会心血管病学分会心力衰竭学组, 中国医师协会心力衰竭专业委员会中华心血管病杂志编辑委员会.中国心力衰竭诊断和治疗指南2018 [J]. 中华心血管病杂志, 2018, 46(10): 760.
|
|
[5]
|
徐洁, 骆小梅, 张颖. 慢性心力衰竭患者血清脂联素水平与心功能及左室重构的相关性[J]. 中国老年学杂志, 2017, 37(1): 91-93.
|
|
[6]
|
Hung, C.L., Hung, T.C., Lai, Y.H., et al. (2013) Beyond Malignancy: The Role of Carbohydrate Antigen 125 in Heart Failure. Biomarker Research, 1, 25. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Ueland, T., Gullestad, L., Nymo, S.H., et al. (2015) Inflammatory Cytokines as Biomarkers in Heart Failure. Clinica Chimica Acta, 443, 71-77. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
王莹莹, 陶绍能, 戴云海, 等. 血清CA125在慢性心力衰竭患者中的临床价值[J]. 皖南医学院学报, 2019, 38(4): 354-356.
|
|
[9]
|
付祥真, 罗霖, 丁雪峰, 等. 糖类抗原125对心力衰竭患者预后预测价值的Meta分析[J]. 临床心血管病杂志, 2020, 36(12): 1098-1103.
|
|
[10]
|
Xie, Y.T., Dang, Y., Zhang, F.F., et al. (2020) Combination of Serum TIMP-3, CA125, and NT-proBNP in Predicting Ventricular Remodeling in Patients with Heart Failure Following Acute Myocardial Infarction. Cardiovascular Diagnosis and Therapy, 10, 1184-1191. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Stanciu, A.E., Stanciu, M.M. and Vatasescu, R.G. (2018) NT-proBNP and CA 125 Levels Are Associated with Increased Pro-Inflammatory Cytokines in Coronary Sinus Serum of Patients with Chronic Heart Failure. Cytokine, 111, 13-19. [Google Scholar] [CrossRef] [PubMed]
|